期刊文献+

CD4+CD25+Treg细胞对肿瘤特异性CTL杀伤效果的影响 被引量:5

Effects of CD4 + CD25 + Treg on the killing effects of tumor-specific cytotoxicity of CTL
原文传递
导出
摘要 目的 探讨CD4+CD25+Treg细胞对肿瘤特异性细胞毒T细胞(CTL)杀伤效果的影响及机制.方法 将C57BL/6小鼠80只随机分为4组,每组20只.A组:树突状细胞(DC)与T细胞共同培养前删除CD4+CD25+Treg;B组:DC与T细胞共同培养后删除CD4+CD25+Treg;C组:DC与T细胞共同培养时不删除CD4+CD25+Treg;对照组:无DC诱导的T细胞.应用脾脏来源DC细胞诱导T细胞制备CTL,在CTL形成的不同时期采用MACS法删除CD4+CD25+Treg.应用噻唑蓝(MTY)比色法检测不同组别CTL对B16黑色素瘤细胞的杀伤效果.同时应用酶联免疫吸附试验(ELISA)法检测细胞培养液中白细胞介素(IL)-2、干扰素(IFN)-γ含量变化.结果 3组实验组CTL杀伤率明显高于对照组(P〈0.05).删除CD4+CD25+Treg的A组、B组CTL杀伤率明显高于未删除的C组(P〈0.05).但CTL形成的不同时期删除CD4+CD25+Treg对CTL杀伤率的影响无统计学意义(P〉0.05).IL-2、IFN-γ含量变化与杀伤率呈现相同的变化趋势.结论 删除CD4+CD25+Treg细胞可明显提高CTL的杀伤效果,是消除肿瘤免疫耐受机制的新途径. Objective To explore the killing effects of CD4 + CD25 + Treg on tumor-specific cytotoxicity of cytotoxic T lymphocyte (CTL) to B16 Melanoma and the action mechanism.Methods Eighty C57BL/6 mice were randomly divided into three experimental groups and one control group (n = 20 each group).Mononuclear cells were isolated from spleen tissues of the mice,and CTLs were prepared by using DCs loaded with B16 tumor antigens.Tumor inhibition rate was evaluated by using methyl thiazol tetrazolium (MTY) assay in vitro after deletion of CD4 + CD25 + Treg by using MACS,and the secretion levels of interleukin-2 (IL-2) and interferon-γ (IFN-γ) in the supernatant of the cell culture were measured by using enzyme linked immunosorbent assay (ELISA).Results Tumor inhibition rate in three experiment groups was significantly higher than that in control group ( P 〈 0.05 ).Tumor inhibition rate in groups A and B with a deletion of CD4 + CD25 + Tregs was significantly increased as compared with group C without deletion of Tregs ( P 〈 0.05 ),but no significant difference was found between groups A and B with deletion of Tregs before and after the culturing ( P 〉 0.05 ).The difference in the IL-2 and IFN-γwas the same as the tumor tumor inhibition effeciency of antigen-specific CTLs,which might be a new way to breakdown the tumor immune tolerance.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2010年第12期1859-1861,共3页 Chinese Journal of Experimental Surgery
基金 河北省卫生厅重点课题(08120)
关键词 T细胞 树状突细胞 白细胞介素-2 干扰素-Γ 免疫耐受 T cell Dendritic cell Interleukin-2 Interferon-γ Immune tolerance
  • 相关文献

参考文献10

  • 1Dudley ME,Wunderlich JR,Shelton TE,et al.Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients.Immunother,2003,26:332-342.
  • 2Orentas RJ,Kohler ME,Johnson BD,et al.Suppression of anti-cancer immunity by regulatory T cells:back to future.Semin Cancer Biol,2006,16:137-149.
  • 3王凌云,黄开红,闵军,苏红,朱兆华.胃癌患者外周血调节性T细胞的多种细胞因子水平的检测及其意义[J].中华实验外科杂志,2006,23(11):1375-1377. 被引量:18
  • 4Blazar BR,Taylor PA.Regulatory T cells.Biol Blood Marrow Transplant,2005,11:46-49.
  • 5Dudley ME,Yang JC,Sherry R,et al.Adoptive cell therapy for patients with metastatic melanoma:evaluation of intensive myeloablative chemoradiation preparative regimens.Clin Oncol,2008,26:5233-5239.
  • 6Yamaguchi T,Sakaguchi S,Aderson DE,et al.Regulatory T cells in immune surveillance and treatment of cancer.Semin Cancer Biol,2006,16:115-123.
  • 7周军,汪建平,兰平,吴小剑,黄美近,宋新明.结肠抗原特异性T细胞克隆回输治疗大鼠溃疡性结肠炎的研究[J].中华实验外科杂志,2004,21(10):1206-1208. 被引量:14
  • 8Chattopadhyay S,Chakraborty NG,Mukherji B,et al.Regulatory T cells and tumor immunity.Cancer Immunol Immunother,2005,54:1153-1161.
  • 9Hersey P,Halliday GM,Farrelly ML,et al.Phase Ⅰ/Ⅱ study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma.Cancer Immunol Immunother,2008,57:1039-1051.
  • 10Nakai N,Katoh N,Germeraad WT,et al.Immunohistological analysis of peptide-induced delayed-type hypersensitivity in advanced melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination.Dermatol Sci,2009,53:40-47.

二级参考文献10

  • 1Shapira OM,Mpr E,Reshef T et al.Prolongation of survival of rat cardiac allografts by T cell vaccination.J Clin Invest,1993,91:388-390.
  • 2Elson CO.Experimental models of inflammatory bowel disease.Gastroenterology,1995,109:1344.
  • 3Linda MB,Keiko Y,Susan LS.The cytokines IL-4,IFN-γ,and IL-12 regulate the development of memory effector helper T cells in vitro.J Immunol,1995,155:1713-1724.
  • 4Neurath M,Finotto S,Fuss I,et al.TRENDS in Immunol.Surg,2001,22:21-26.
  • 5Webb S,Morris C,Sprent J.Extrathymic tolerance of mature T cells:clonal elimination as a consequence of immunity.Cell,1990,63:1249-1256.
  • 6Tung YT,Andrea D,Saiho K,et al.Specific immunosuppression by postoperative infusion of allogeneic spleen cells.Transplantation,2000,69:25-30.
  • 7Green EA,Choi Y,Flavell RA.Pancreatic lymphnode-derived CD4+CD25+ T reg cells:highly potent regulators of diabetes that require TRANCE-RANK signals.Immunity,2002,16:183-191.
  • 8王凌云 黄开红 朱兆华 等.胃癌患者PBMCs中CD4^+CD25^+调节T细胞的分选及体外增殖分析[J].中国免疫学杂志,2005,21:73-73.
  • 9Zheng SG, Wang JH, Gray JD, et al. Natural and induced CD4^+ CD25^+ cells educate CD4^+ CD25^- cells to develop suppressive activity: the role of IL-2, TGF-β and IL-10. J Immunol, 2004,172:5213-5221.
  • 10Tanaka H, Tanaka J, Kjaergaard J, et al. Depletion of CD4^+ CD25^+ regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodes. J Immunother, 2002,25 : 207-217.

共引文献29

同被引文献67

  • 1Chiang YJ, Kole HK, Brown K, et al. Cbl-b regulates the CD28 de- pendence of T-cell activation. Nature,2000,403:216-220.
  • 2Chiang JY, Jang IK, Hodes R, et al. Ablation of Cbl-b provides protec- tion against transplanted and spontaneous tumors. J Clin Invest,2007, 117 : 1029-1036.
  • 3Loeser S, Loser K, Bijker MS, et al. Spontaneous tumor rejection by cbl-b-deficient CD8 + Tcells. J Exp Med,2007,204:879-891.
  • 4Stromnes IM, Blattman JN,Tan X, et al. Abrogating Cbl-b in effeetor CD8 + Tcells improves the efficacy of adoptive therapy of leukemia in mice. J Clin Invest,2010,120:3722-3734.
  • 5Wang X, Yu J, Sreekumar A, et al. Autoantibody signatures in prostate cancer. N Engl J Med,2005,353 : 1224-1235.
  • 6Harzstark AL, Small EJ. Immunotherapeutics in development for pros- tate cancer. Oncologist,2009,14 : 391-398.
  • 7Naramura M,Jang IK,Kole H, et al. C-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-indueed TCR down-modulation. Nat hnmuno1,2002,3 : 1192-1199.
  • 8FU G,Chen Y,Yu M,et al. Phospholipase C3,1 is essential for T cell dexelopment, activation, and tolerance. J Exp Med, 2010,207 : 309- 318.
  • 9Lopez-Camarillo C,Marchat LA,Arechaga-Ocampo E. MetastamiRs:noncoding microRNAs driving cancer invasion and metastasis[J].INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,2012.1347-1379.
  • 10Dunn GP,Bruce AT,Ikeda H. Cancer immunoediting:from immunosurveillance to tumor escape[J].Nature Immunology,2002.991-998.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部